TP53 status and gene amplification in human colorectal carcinomas

被引:6
|
作者
Soulié, P
Fourme, E
Hamelin, R
Asselain, B
Salmon, RJ
Dutrillaux, B
Muleris, M
机构
[1] Inst Curie, CNRS UMR147, F-75248 Paris 05, France
[2] Inst Curie, Unite Biostat, F-75248 Paris 05, France
[3] Inst Curie, Dept Surg, F-75248 Paris 05, France
[4] INSERM U434 CEPH, Paris, France
关键词
D O I
10.1016/S0165-4608(99)00073-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gene amplification is one of the characteristics of cancer cells. In vitro studies suggested that alterations of the TP53 gene might be responsible for gene amplification. We have examined the presence of TP53 mutations and looked for cytogenetic evidence of gene amplification in a series of 79 primary colorectal carcinomas. Of her parameters such as the pattern of cytogenetic alterations, microsatellite instability tumor site, and histological staging were of so considered. A multiparametric study supported by statistical analyses suggests the existence of two major path was of colorectal carcinogenesis. No relationships could be established between the presence of TP53 alterations and gene amplification. (C) 1999 Elsevier Science, Inc. All rights reserved.
引用
收藏
页码:118 / 122
页数:5
相关论文
共 50 条
  • [31] The relationship between TP53 gene status and carboxylesterase 2 expression in human gastric cancer
    Kohira, Yoshinori
    Lee, Hyeon-Cheol
    Ishimine, Momoko
    Orita, Hajime
    Kobayashi, Toshiyuki
    Sato, Koichi
    Yokomizo, Takehiko
    Fukunaga, Tetsu
    CANCER RESEARCH, 2019, 79 (13)
  • [32] THE TP53 TUMOR SUPPRESSOR GENE IN COLORECTAL CARCINOMAS .2. RELATION TO DNA PLOIDY PATTERN AND CLINICOPATHOLOGICAL VARIABLES
    MELING, GI
    LOTHE, RA
    BORRESEN, AL
    GRAUE, C
    HAUGE, S
    CLAUSEN, OPF
    ROGNUM, TO
    BRITISH JOURNAL OF CANCER, 1993, 67 (01) : 93 - 98
  • [33] P53/Tp53 status in keratoacanthomas
    Joshi, S.
    Schjolberg, A.
    De Angelis, P. M.
    Ekstrom, P. O.
    Clausen, O. P.
    VIRCHOWS ARCHIV, 2015, 467 : S48 - S48
  • [34] Tp53/p53 status in keratoacanthomas
    Joshi, Sarita
    Schjolberg, Aasa R.
    Ekstrom, Per Olaf
    De Angelis, Paula M.
    Zucknick, Manuela
    Andersen, Solveig Norheim
    Clausen, Ole Petter F.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2016, 43 (07) : 571 - 578
  • [35] TP53 Gene Status Affects Survival in Advanced Mycosis Fungoides
    Wooler, Gitte
    Melchior, Linea
    Ralfkiaer, Elisabeth
    Gjerdrum, Lise Mette Rahbek
    Gniadecki, Robert
    FRONTIERS IN MEDICINE, 2016, 3
  • [36] Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway
    Saba, Karim H.
    Difilippo, Valeria
    Kovac, Michal
    Cornmark, Louise
    Magnusson, Linda
    Nilsson, Jenny
    van den Bos, Hilda
    Spierings, Diana C. J.
    Bidgoli, Mahtab
    Jonson, Tord
    Sumathi, Vaiyapuri P.
    Brosjoe, Otte
    Staaf, Johan
    Foijer, Floris
    Styring, Emelie
    Nathrath, Michaela
    Baumhoer, Daniel
    Nord, Karolin H.
    JOURNAL OF PATHOLOGY, 2024, 262 (02): : 147 - 160
  • [37] Why are there hotspot mutations in the TP53 gene in human cancers?
    Baugh, Evan H.
    Ke, Hua
    Levine, Arnold J.
    Bonneau, Richard A.
    Chan, Chang S.
    CELL DEATH AND DIFFERENTIATION, 2018, 25 (01): : 154 - 160
  • [38] MDM2 gene amplification is correlated to tumor progression but not to the presence of SNP309 or TP53 mutational status in primary colorectal cancers
    Forslund, Ann
    Zeng, Zhaoshi
    Qin, Li-Xuan
    Rosenberg, Shoshana
    Ndubuisi, MacKevin
    Pincas, Hanna
    Gerald, William
    Notterman, Daniel A.
    Barany, Francis
    Paty, Philip B.
    MOLECULAR CANCER RESEARCH, 2008, 6 (02) : 205 - 211
  • [39] Why are there hotspot mutations in the TP53 gene in human cancers?
    Evan H Baugh
    Hua Ke
    Arnold J Levine
    Richard A Bonneau
    Chang S Chan
    Cell Death & Differentiation, 2018, 25 : 154 - 160
  • [40] DETECTION OF TP53 GENE-MUTATIONS IN HUMAN SARCOMAS
    CASTRESANA, JS
    RUBIO, MP
    GOMEZ, L
    KREICBERGS, A
    ZETTERBERG, A
    BARRIOS, C
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (05) : 735 - 738